| Patents for A61K 48 - Medicinal preparations containing genetic material which is inserted into cells of the living body to treat genetic diseases; Gene therapy (86,964) |
|---|
| 01/10/2002 | WO2002002797A2 Regulation of human 11 beta-hydroxysteroid dehydrogenase 1-like enzyme |
| 01/10/2002 | WO2002002790A1 Peptide-mediated ocular cell transfection |
| 01/10/2002 | WO2002002789A2 Compositions and methods for producing recombinant virions |
| 01/10/2002 | WO2002002783A2 Expression vectors |
| 01/10/2002 | WO2002002782A1 Activation of gene expression in cloned eukaryotic genomic dna and methods of use thereof |
| 01/10/2002 | WO2002002775A2 Calpain protease 12 |
| 01/10/2002 | WO2002002772A2 Human extracellular matrix (ecm)-related tumor marker |
| 01/10/2002 | WO2002002770A1 Novel g protein-coupled receptor protein and dna thereof |
| 01/10/2002 | WO2002002765A2 Chimeric promoters for controlling expression in smooth muscle cells |
| 01/10/2002 | WO2002002756A2 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment or diagnosis of atherosclerosis |
| 01/10/2002 | WO2002002744A2 Dna encoding a human melanin concentrating hormone receptor (mch1) and uses thereof |
| 01/10/2002 | WO2002002743A2 The nip3 family of proteins |
| 01/10/2002 | WO2002002625A2 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | WO2002002619A1 The t-cell protein (tzon7), peptides and antibodies derived therefrom and uses thereof |
| 01/10/2002 | WO2002002606A2 Immunisation against chlamydia pneumoniae |
| 01/10/2002 | WO2002002600A2 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR27, AND USES THEROF |
| 01/10/2002 | WO2002002599A2 HUMAN G PROTEIN-COUPLED RECEPTOR IGPcR17, AND USES THEROF |
| 01/10/2002 | WO2002002593A2 Modulators of cellular proliferation and angiogenesis, methods for use and identification thereof |
| 01/10/2002 | WO2002002587A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | WO2002002586A1 Isolated nucleic acids and polypeptides associated with glucose homeostasis disorders and method of detecting the same |
| 01/10/2002 | WO2002002148A2 Dual recombinant gene therapy compositions and methods of use |
| 01/10/2002 | WO2002002131A2 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/10/2002 | WO2002002011A1 Dna encoding human serine protease d-g |
| 01/10/2002 | WO2001094636A8 Compositions, kits, and methods for identification and modulation of type i diabetes |
| 01/10/2002 | WO2001085973A9 Antisense type gene trap vector |
| 01/10/2002 | WO2001074164A9 Methods of modulating hair growth |
| 01/10/2002 | WO2001070775A3 Wnt-1 related polypeptides, and nucleic acids encoding the same |
| 01/10/2002 | WO2001070175A3 Osteocalcin promoter directed adenovirus replicaton for therapy |
| 01/10/2002 | WO2001059071A3 Methods of preparing and using a viral vector library |
| 01/10/2002 | WO2001055362A3 Hybrid adeno-retroviral vector for the transfection of cells |
| 01/10/2002 | WO2001055307A3 Nucleic acids, proteins, and antibodies |
| 01/10/2002 | WO2001048483A3 Method for screening of appetite control agents |
| 01/10/2002 | WO2001045730A3 Tweak receptor |
| 01/10/2002 | WO2001045548A3 Surgical needle with weeping tip and method of use |
| 01/10/2002 | WO2001044455A3 Antisense oligonucleotides for the inhibition of expression of type i procollagen |
| 01/10/2002 | WO2001042466A3 Zvwf1: a member of the von willebrand factor type a domain superfamily |
| 01/10/2002 | WO2001042444A3 Methods for expression of genes in primates |
| 01/10/2002 | WO2001042437A3 Histone deacetylase-8 proteins, nucleic acids, and methods of use |
| 01/10/2002 | WO2001040279A3 Hbv sequences |
| 01/10/2002 | WO2001040276A3 Serpentine transmembrane antigens expressed in human prostate cancers and uses thereof |
| 01/10/2002 | WO2001036452A3 Heteroclitic analogs of class i epitodes |
| 01/10/2002 | WO2001034649A3 Compositions and methods for treating autoimmune diseases and transplant rejections |
| 01/10/2002 | WO2001029217A3 Novel polypeptides and polynucleotides encoding same |
| 01/10/2002 | WO2001012664A3 Notch receptor ligands and uses thereof |
| 01/10/2002 | WO2001011048B1 Therapeutic polypeptides and methods for using same |
| 01/10/2002 | WO2001000829A3 Human endogenous retrovirus in breast cancer |
| 01/10/2002 | WO2000075347A3 Tet repressor-based transcriptional regulatory proteins |
| 01/10/2002 | WO2000066162A9 Mutant human cd80 and compositions for and methods of making and using the same |
| 01/10/2002 | WO2000055332A3 Human regulators of intracellular phosphorylation |
| 01/10/2002 | US20020004589 Detecting sensitivity to kidney disease |
| 01/10/2002 | US20020004581 Polypeptide; for use in te diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004580 Polypeptide; for use in the diagnosis and treatment of microorganismal infections; bactericides |
| 01/10/2002 | US20020004492 Polypeptides; wound healing agent, antiinflammatory agent |
| 01/10/2002 | US20020004489 Retinoid receptor interacting polynucleotides, polypeptides, and antibodies |
| 01/10/2002 | US20020004488 Gene therapy |
| 01/10/2002 | US20020004482 Treatment of acute lung injury and fibrosis with antagonists of avbeta6 |
| 01/10/2002 | US20020004239 Nucleotide sequences coding genetically engineered polypeptide; for use in the treatment of mammary gland cancer |
| 01/10/2002 | US20020004042 Gene therapy for pulmonary edema using adenovirus vectors encoding a beta2adrenergic receptor gene |
| 01/10/2002 | US20020004041 Inducing tolerance in mammals to antigen via isolating peripheral blood mononuclear cells, then isolating dendritic cells and exposing to apoptotic cells in absence of cell surface glycoprotein receptors for HIV; prophylaxis |
| 01/10/2002 | US20020004040 Complementary adenoviral vector systems and cell lines |
| 01/10/2002 | DE10128980A1 Genetically modified T cells, useful e.g. for inhibiting allogenic transplant rejection, produced by incubating recipient and donor T cells then transducing with immunomodulatory gene |
| 01/10/2002 | DE10031932A1 Calpain-Protease 12 Calpain protease 12 |
| 01/10/2002 | DE10030149A1 Use of novel polypeptide or its variant or nucleic acid encoding the polypeptide for diagnosing and/or preventing and/or treating skin disorders and/or treatment in wound healing or for identifying active substances |
| 01/10/2002 | CA2415123A1 Novel fibroblast growth factors and nucleic acids encoding same |
| 01/10/2002 | CA2414884A1 Immunisation against chlamydia pneumoniae |
| 01/10/2002 | CA2414621A1 Gene expression in biological conditions |
| 01/10/2002 | CA2414592A1 Calpain protease 12 |
| 01/10/2002 | CA2414375A1 Glycosylphosphatidylinositol specific phospholipase d proteins for the treatment or diagnosis of atherosclerosis |
| 01/10/2002 | CA2414328A1 Chimeric promoters for controlling expression in smooth muscle cells |
| 01/10/2002 | CA2413756A1 Dna encoding human serine protease d-g |
| 01/10/2002 | CA2413250A1 The nip3 family of proteins |
| 01/10/2002 | CA2413158A1 Ecm-related tumor marker |
| 01/10/2002 | CA2412847A1 Dual recombinant gene therapy compositions and methods of use |
| 01/10/2002 | CA2411692A1 Compositions and methods for the diagnosis and treatment of herpes simplex virus infection |
| 01/10/2002 | CA2406649A1 B7-like polynucleotides, polypeptides, and antibodies |
| 01/09/2002 | EP1170374A1 Method for preperation of microprojectiles for efficient delivery of biologicals using a particle gun |
| 01/09/2002 | EP1170373A1 Peptide-mediated ocular cell transfection |
| 01/09/2002 | EP1170368A2 Immunization by inoculation of dna transcription unit |
| 01/09/2002 | EP1170363A1 Virus envelope vector for gene transfer |
| 01/09/2002 | EP1169480A1 Tissue-specific and pathogen-specific toxic agents and ribozymes |
| 01/09/2002 | EP1169475A1 Diagnosis of a person's risk for developing atherosclerosis or diabetic retinopathy |
| 01/09/2002 | EP1169469A1 Human colon cancer associated gene sequences and polypeptides |
| 01/09/2002 | EP1169459A1 Dsp-9 dual-specificity map kinase phosphatase |
| 01/09/2002 | EP1169449A2 Clasp-2 transmembrane proteins |
| 01/09/2002 | EP1169446A2 Compounds for immunotherapy and diagnosis of breast cancer and methods for their use |
| 01/09/2002 | EP1169445A2 Human proteins and polynucleotides encoding them |
| 01/09/2002 | EP1169444A2 Compositions and methods for the treatment and diagnosis of breast cancer |
| 01/09/2002 | EP1169442A2 Secreted and transmembrane polypeptides and nucleic acids encoding the same |
| 01/09/2002 | EP1169441A2 Treatment of cardiac power failure using s100 proteins |
| 01/09/2002 | EP1169440A1 48 human secreted proteins |
| 01/09/2002 | EP1169350A2 Human obesity protein binding protein-2 homolog compositions and uses thereof |
| 01/09/2002 | EP1169347A2 Compounds and methods for therapy and diagnosis of lung cancer |
| 01/09/2002 | EP1169346A1 48 human secreted proteins |
| 01/09/2002 | EP1169345A2 Genes associated with diseases of the kidney |
| 01/09/2002 | EP1169344A1 47 human secreted proteins |
| 01/09/2002 | EP1169343A2 Flea head, nerve cord, hindgut and malpighian tubule nucleic acid molecules, proteins and uses thereof |
| 01/09/2002 | EP1169342A2 Tuberculosis antigens and methods of use therefor |
| 01/09/2002 | EP1169334A1 48 human secreted proteins |
| 01/09/2002 | EP1169333A1 49 human secreted proteins |
| 01/09/2002 | EP1169054A2 Products and methods for treating ptp lar related diseases |